IP Library Granted Patent US 7,125,975
Granted Patent B2
US 7,125,975 · App. 10/755,166 · Granted Oct 24, 2006

Derivatized oligonucleotides having improved uptake and other properties

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,125,975
App. No.
10/755,166
Granted
Oct 24, 2006
Kind
B2
Abstract

Linked nucleosides having at least one functionalized nucleoside that bears a substituent such as a steroid molecule, a reporter molecule, a non-aromatic lipophilic molecule, a reporter enzyme, a peptide, a protein, a water soluble vitamin, a lipid soluble vitamin, an RNA cleaving complex, a metal chelator, a porphyrin, an alkylator, a pyrene, a hybrid photonuclease/intercalator, or an aryl azide photo-crosslinking agent exhibit increased cellular uptake and other properties. The substituent can be attached at the 2′-position of the functionalized nucleoside via a linking group. If at least a portion of the remaining liked nucleosides are 2′-deoxy-2′-fluoro, 2′-O-methoxy, 2′-O-ethoxy, 2′-O-propoxy, 2′-O-aminoalkoxy or 2′-O-allyloxy nucleosides, the substituent can be attached via a linking group at any of the 3′ or the 5′ positions of the nucleoside or on the heterocyclic base of the nucleoside or on the inter-nucleotide linkage linking the nucleoside to an adjacent nucleoside.

Claims (12)

1. A compound comprising a plurality of linked nucleosides, wherein:

at least one of the nucleosides is a 2′-deoxy′-2′-fluoro, 2′-O—C 1 –C 20 -alkyl, 2′-O—C 2 –C 20 -alkenyl, 2′-O—C 2 –C 20 -alkynyl, 2′-S—C 1 –C 20 -alkyl, 2′-S—C 2 –C 20 -alkenyl, 2′-S—C 2 –C 20 -alkynyl, 2′-NH—C 1 –C 20 -alkyl, 2′-NH—C 2 –C 20 -alkenyl, or 2′-NH—C 2 –C 20 -alkynyl nucleoside; and

at least one of the nucleosides is a 5′-O-terminal nucleoside having a non-aromatic lipophilic molecule linked to the 5′-O-position of the nucleoside, provided that the compound does not include sulfamate or sulfamide internucleotide linkages.

2. The compound of claim 1 wherein at least one of said nucleosides is a 2′-deoxy-2′-fluoro or a 2′-methoxy nucleoside.

3. A compound comprising a plurality of linked nucleosides, wherein:

at least one of the nucleosides is a 2′-deoxy′-2′-fluoro, 2′-O—C 1 –C 20 -alkyl, 2′-O—C 2 –C 20 -alkenyl, 2′-O—C 2 –C 20 -alkynyl, 2′-S—C 1 –C 20 -alkyl, 2′-S—C 2 –C 20 -alkenyl, 2′-S—C 2 –C 20 -alkynyl, 2′-NH—C 1 –C 20 -alkyl, 2′-NH—C 2 –C 20 -alkenyl, or 2′-NH—C 2 –C 20 -alkynyl nucleoside; and

at least one of the nucleosides is a 5′-O-terminal nucleoside having a non-aromatic molecule linked to the 5′-O-position of the nucleoside, provided that the compound does not include sulfamate or sulfamide internucleotide linkages.

4. The compound of claim 3 wherein at least one of said nucleosides is a 2′-deoxy-2′-fluoro or a 2′-methoxy nucleoside.

5. A compound comprising a plurality of linked nucleosides, wherein:

at least one of the nucleosides is a 2′-deoxy′-2′-fluoro, 2′-O—C 1 –C 20 -alkyl, 2′-O—C 2 –C 20 -alkenyl, 2′-O—C 2 –C 20 -alkynyl, 2′-S—C 1 –C 20 -alkyl, 2′-S—C 2 –C 20 -alkenyl, 2′-S—C 2 –C 20 -alkynyl, 2′-NH—C 1 –C 20 -alkyl, 2′-NH—C 2 –C 20 -alkenyl, or 2′-NH—C 2 –C 20 -alkynyl nucleoside; and

at least one of the nucleosides is a 5′-O-terminal nucleoside having a lipophilic molecule linked to the 5′-position of the nucleoside, provided that the compound does not include sulfamate or sulfamide internucleotide linkages.

6. The compound of claim 5 wherein at least one of said nucleosides is a 2′-deoxy-2′-fluoro or a 2′-methoxy nucleoside.